MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-30-2025
DexCom ROA Ratio 2011-2025 | DXCM
Annual ROA Ratio DexCom
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.64 | 6.33 | 4.4 | 12.81 | 4.22 | -6.63 | -5.55 | -16.29 | -19.73 | -12.13 | -24.33 | -51.42 | -37.14 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.81 | -51.42 | -10.52 |
Quarterly ROA Ratio DexCom
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.25 | 7.91 | 6.49 | 8.32 | 8.03 | 7.62 | 4.41 | 6.48 | 6.71 | 6.94 | 5.91 | 7.74 | 5.58 | 6.98 | 4.51 | 6.19 | 6.05 | 5.73 | 3.23 | 7.1 | 7.33 | 5.81 | 4.22 | -9.03 | -8.51 | -6.49 | -6.63 | 1.71 | -0.95 | -2.2 | -5.55 | -6.35 | -10.8 | -16.13 | -16.29 | -13.94 | -23.82 | -20.07 | -19.73 | -19.54 | -7.8 | -9.78 | -12.13 | -14.96 | -17.04 | -22.04 | -24.33 | -30.22 | -41.65 | -47.27 | -51.51 | -53.62 | -48.33 | -40.61 | -37.1 | -11.04 | -6.14 | -9.79 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.32 | -53.62 | -9.0 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-8.53 | $ 18.68 | -3.56 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 20.26 | -6.03 % | $ 218 M |  China |
 |
Co-Diagnostics
CODX
|
-37.07 | $ 0.23 | -3.83 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 39.13 | -0.67 % | $ 1.09 B | USA |
 |
Danaher Corporation
DHR
|
5.03 | $ 230.63 | 0.13 % | $ 169 B | USA |
 |
BioNano Genomics
BNGO
|
-146.1 | $ 1.51 | -0.66 % | $ 1.92 M | USA |
 |
DarioHealth Corp.
DRIO
|
-61.65 | $ 10.22 | 1.79 % | $ 290 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Exact Sciences Corporation
EXAS
|
-14.58 | $ 101.55 | -0.02 % | $ 18.8 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 26.58 | -0.52 % | $ 804 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-40.76 | $ 19.2 | -1.41 % | $ 1.03 B | USA |
 |
Celcuity
CELC
|
-45.6 | $ 100.79 | -1.43 % | $ 3.98 B | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
-58.14 | $ 3.15 | -1.56 % | $ 100 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
5.1 | $ 226.62 | -0.13 % | $ 41.1 B | USA |
 |
Guardant Health
GH
|
-29.37 | $ 102.07 | -0.88 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
-12.39 | $ 6.4 | -1.23 % | $ 580 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-258.47 | $ 4.92 | -1.4 % | $ 2.64 M | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 7.27 | 1.94 % | $ 1.58 B | USA |
 |
Illumina
ILMN
|
-19.4 | $ 134.24 | -0.53 % | $ 21.3 B | USA |
 |
Charles River Laboratories International
CRL
|
0.29 | $ 202.71 | -0.41 % | $ 10.4 B | USA |
 |
National Research Corporation
NRC
|
25.3 | $ 18.43 | -1.23 % | $ 452 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.39 | $ 175.51 | -0.26 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
-44.15 | $ 6.65 | -2.57 % | $ 862 M | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
4.06 | $ 253.42 | -0.21 % | $ 21.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 182.22 | -0.34 % | $ 15 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
26.96 | $ 685.3 | -0.46 % | $ 56.5 B | USA |
 |
Lantheus Holdings
LNTH
|
15.78 | $ 67.03 | 0.48 % | $ 4.64 B | USA |
 |
Mettler-Toledo International
MTD
|
26.64 | $ 1 413.45 | -0.48 % | $ 30 B |  Schweiz |
 |
Agilent Technologies
A
|
11.3 | $ 138.24 | -0.11 % | $ 42 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
10.73 | $ 27.33 | 0.83 % | $ 20 B |  Niderland |
 |
Biomerica
BMRA
|
-83.65 | $ 2.7 | - | $ 6.2 M | USA |
 |
Bioventus
BVS
|
-19.27 | $ 7.47 | 0.13 % | $ 468 M | USA |
 |
Personalis
PSNL
|
-30.08 | $ 8.13 | -0.12 % | $ 482 M | USA |